Tag:
Novus
Ghost Bites
Ghost Bites (AfroCentric | Aspen | Novus – Mustek)
Aspen announced the disposal of Aspen APAC and the market loved it. AfroCentric is disposing of Activo and the market forgot to notice - for now, at least. And for Novus, a purchase of 3,000 shares has turned out to be very expensive in the Mustek deal.
Ghost Bites
Ghost Bites (Mr Price | NEPI Rockcastle)
Mr Price isn't backing off on the NKD deal, despite the absolute hatred for the transaction from the market. NEPI's pre-close update shows the importance of looking at per-share growth.
Ghost Bites
Ghost Bites (Curro | Hulamin | Labat Africa | Sanlam)
The Curro deal gets the green light. Sanlam is doing important deals in India across the various Shriram investments. Labat Africa's numbers look very interesting. Hulamin's full year numbers are likely to be awful.
Ghost Bites
Ghost Bites (Accelerate Property Fund | Deneb | eMedia | Frontier Transport | Growthpoint | HCI | KAL | Life Healthcare | Nampak |...
A huge day of news saw the HCI stable (including Deneb, eMedia, Frontier Transport and Tsogo Sun) release results. Growthpoint released a quarterly update. Nampak is a great turnaround story, while Accelerate Property Fund is also coming right. Numbers came in from KAL, Life Healthcare and Novus as well, while Sirius Real Estate announced another acquisition.
DealMakers
Weekly corporate finance activity by SA exchange-listed companies
Weekly summary of corporate finance activity by South African exchange listed companies
Ghost Bites
Ghost Bites (Harmony Gold | Invicta | Netcare | Oceana | PPC | Prosus – Naspers | Stefanutti Stocks)
Prosus - Naspers is growing strongly, with all eyes on the Just Eat Takeaway.com integration. PPC's turnaround strategy is working incredibly well. Invicta and Netcare both took advantage of share buybacks. Oceana was dragged down by fish oil prices. Harmony Gold is pushing further into copper. Stefanutti Stocks has settled with Eskom.
Ghost Bites
Ghost Bites (Aspen | ASP Isotopes | Boxer | Calgro M3 | Canal+ and MultiChoice)
Boxer's underlying story is good, but the IPO ruined profit growth. Canal+ will inward list on the JSE after the MultiChoice deal. Calgro M3's earnings fell this period based on infrastructure timing. ASP Isotopes locked in their biggest ever supply deal. Aspen is thrilled that Mounjaro can be prescribed for obesity in SA.
DealMakers
Weekly corporate finance activity by SA exchange-listed companies
Weekly summary of corporate finance activity by South African exchange listed companies
